Anixa Biosciences Inc — Director's Dealing 2014

Feb 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2014-01-24

Reporting Person: Roop John H. (Sr. Vice President-Engineering)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-24	Common Stock	P	1000	$0.26	Acquired	1000	Direct
2014-01-24	Common Stock	P	10000	$0.27	Acquired	11000	Direct
2014-01-24	Common Stock	P	8500	$0.29	Acquired	19500	Direct
2014-01-24	Common Stock	P	10000	$0.3	Acquired	29500	Direct
2014-01-28	Common Stock	P	50000	$0.34	Acquired	79500	Direct
2014-01-29	Common Stock	P	50000	$0.4	Acquired	129500	Direct